ImmuCell Corporation (ICCC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.55
• Market Cap: $54.73M
• P/E Ratio: 28.81
• EPS: $0.21
• 52-Week High: $7.60
• 52-Week Low: $4.28

About ImmuCell Corporation

ImmuCell Corporation (ICCC) is a prominent player in the animal health industry, dedicated to enhancing the well-being and productivity of dairy and beef cattle through cutting-edge biological products. Based in Portland, Maine, the company focuses on the development and commercialization of proprietary solutions that significantly improve livestock health and performance. ImmuCell prides itself on its commitment to sustainability and innovative practices, positioning itself to leverage growt...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ImmuCell Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ICCC pay dividends?

ImmuCell Corporation (ICCC) does not currently pay a regular dividend.

What is ICCC's P/E ratio?

ImmuCell Corporation has a price-to-earnings (P/E) ratio of 28.81.

What is ICCC's market cap?

ImmuCell Corporation (ICCC) has a market capitalization of $54.73M with a current stock price of $6.55.